PainCeptor Pharma Corporation is a Canadian-based, private biopharmaceutical company focused on the development of safe, effective and peripherally-active pharmaceuticals for the management of chronic and acute pain.

Our researchers and industrial collaborators maintain a leadership position in the development of highly-selective organic molecules which will alleviate pain in a number of debilitating untreated diseases. 

PainCeptor’s therapeutics work by intercepting tissue-specific pain signals at the source and by promoting a receptive physiological environment for relief of chronic and acute pain.